You are here

psoriasis

AbbVie's stock climbs after positive late-stage trial results of psoriasis treatment

Marketwatch

Mon, 12/4/17 - 09:48 am

clinical trials

A Me-Too Push By Biopharma Is Crowding the Psoriasis Market

Motley Fool

Sun, 10/29/17 - 09:59 am

AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition

Endpoints

Thu, 10/26/17 - 09:28 am

clinical trials

J&J psoriasis drug gets expanded U.S. approval for teens

Yahoo/Reuters

Sat, 10/14/17 - 10:58 am

Thync’s bioelectronics wearable shows promise in psoriasis pilot

Fierce Biotech

Thu, 10/5/17 - 12:48 pm

Novartis touts 5-year Cosentyx data as it works to hold top spot in psoriasis

Fierce Pharma

Wed, 09/13/17 - 09:43 pm

Dr. Reddy's sells off psoriasis candidate in out-licensing deal

BioPharma Dive

Wed, 08/23/17 - 10:04 pm

Encore Dermatology

J&J's Tremfya approved, further crowding IL-inhibitor market

BioPharma Dive

Sat, 07/15/17 - 11:31 am

Interleukin-inhibitors

FDA clears Philips' light therapy wearable for mild psoriasis

Fierce Biotech

Sat, 07/15/17 - 11:16 am

J&J gets a quick FDA OK for its blockbuster psoriasis contender guselkumab

Endpoints

Thu, 07/13/17 - 05:38 pm

Will Low Pricing for Siliq Be Enough to Help Valeant Turn Things Around?

Motley Fool

Tue, 04/25/17 - 11:10 am

Valeant Pharmaceuticals

Black box warning? No worries, Valeant bills Siliq as the ‘low-cost’ psoriasis alternative to rivals from Novartis, Eli Lilly

Endpoints

Fri, 04/21/17 - 11:45 am

Valeant Pharmaceuticals

How a $37,000-a-year medicine sets a good model for drug pricing

Stat

Tue, 04/4/17 - 12:17 am

Merck, Avillion ink development deal for nanobody psoriasis treatment

Mass Device

Fri, 03/31/17 - 09:49 am

Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016

Market Realist

Wed, 03/29/17 - 09:31 am

J&J looks for the inside story with new online psoriasis campaign

Fierce Pharma

Tue, 03/28/17 - 10:54 am

Novartis star Cosentyx, facing new rivals, may gain edge as a disease-modifying med

Fierce Pharma

Tue, 03/21/17 - 10:00 am

Valeant Pharmaceuticals

Does Valeant have the ad dollars to keep Siliq competitive in psoriasis?

Fierce Pharma

Sat, 03/4/17 - 01:55 pm

Valeant Pharmaceuticals

J&J may be late to the psoriasis drug market party, but it’s planning to make a splash with guselkumab

Endpoints

Fri, 03/3/17 - 09:36 am

Purdue Pharma Puts Skin In The Game With Psoriasis Deal

Seeking Alpha

Thu, 12/15/16 - 10:09 am

Pages